Salesforce Stock Has Surged as AI and Anthropic Bets Pay Off, But Technical Risks Remain
Salesforce stock has surged to its highest level in months as its AI and Anthropic bets paid off, but its technical risks remain
Stocks · News reference
Anthropic Is Going All In on Drug Discovery Just as Pharma Stops Talking About AI
Anthropic launches Claude Science for researchers as PwC data shows AI mentions in pharma M&A decline, signaling a shift in AI adoption.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Bloom Energy Stock Faces Key Risks as Growth Fuels S&P 500 Index Inclusion
Bloom Energy jumped to a crucial resistance level as its revenue growth fueled its upcoming inclusion to the S&P 500 Index.
Jensen Huang's Net Worth Up $36 Billion as Nvidia Stock Eyes Surge to Record High
The ongoing Nvidia stock surge has pushed Jensen Huang's net worth by over $48 billion and is the eighth-richest man in the world.
David Sacks Says AI Debate Is Shifting From ‘Doomers’ to Open vs. Closed Models
David Sacks says AI politics is shifting from speed versus caution to open, decentralized systems versus centralized control by major firms.
The Market Just Told You Which Layer Of AI Biology It Is Paying For
Recent earnings in life sciences technology reveal that the market is rewarding companies with proprietary data and systems of record over those selling software or AI models alone. Veeva Systems beat expectations with strong AI product adoption, while Certara missed on modest software growth and Recursion Pharmaceuticals fell short on revenue expectations. MindWalk Holdings, which owns curated biological data infrastructure, is positioned to benefit from this trend with its HYFT Technology and newly launched ReefIQ platform, though it remains unprofitable with modest recurring revenue.